Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2020 Earnings

11MayConfirmed

Q3 2019

Q4 2019

Q1 2020

Q2 2020

-0.24

-0.17

-0.09

-0.02

Details

Expected EPS

-0.02

Actual EPS

-0.04

Surprise EPS

-0.02

Surprise Percent

+100%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.04 per share for Q2 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.